Bone Health Awareness Sale ends in 00days 00hrs 00min
← Learn

Mood Swings After Menopause, and What a New Pearl Powder Study Found in Rats

September 18, 2026 · Optimum Research Team
Mood Swings After Menopause, and What a New Pearl Powder Study Found in Rats

Pearl powder never ships on its own at Optimum. It rides inside the Bone Restore Trifecta next to shilajit, and a 2025 paper out of Ningbo University gives it a second reason to sit there. Sun and colleagues put a pearl powder protein fraction through a rat stress model and measured mood-related behavior. The stressed rats went back to preferring sugar water and stopped giving up as quickly in two standard rodent screens. That is a real result. It is also a rat result, in male rats, with no human trial anywhere behind it.

Why does mood swing so much in the menopause transition?

Why does mood swing so much in the menopause transition?

This part is not speculative, and it is not animal data. It is one of the better documented findings in menopause research.

Freeman and colleagues (2006), working out of the University of Pennsylvania, followed women for eight years. Every woman entered the study premenopausal with no history of depression, which is what makes the result usable. Nobody came in already carrying the thing being measured.

High scores on a standard depressed-mood scale were more than four times more likely during a woman's own menopausal transition than during her own premenopausal years. The odds ratio was 4.29.

That is each woman compared against herself. Not against some other group of women.

What the researchers ruled out

The obvious objection is that midlife is simply hard, and the mood has nothing to do with hormones. The Penn team tested that directly by adjusting the analysis for the things that usually get blamed.

  • Smoking, body mass index, and general health status
  • Premenstrual syndrome history
  • Hot flashes and poor sleep
  • Employment status and marital status

The hormone associations survived all of it. Cohen and colleagues (2006), running an entirely separate cohort of 460 women through Harvard, landed in the same place. Women entering perimenopause were twice as likely to develop significant depressive symptoms as women who stayed premenopausal.

Why the swing matters more than the level

Here is the detail most summaries drop. What tracked with low mood in the Penn data was not a low estradiol number on its own. It was increased variability of estradiol around each woman's own average, along with the same instability in follicle stimulating hormone and luteinizing hormone.

The signal is the turbulence, not the floor.

That reframes the complaint entirely. A woman describing herself as fine one hour and undone the next is not being dramatic about a steady decline. She is describing a genuinely unsteady input, and her brain chemistry is downstream of it.

What did the new pearl powder study actually find?

What did the new pearl powder study actually find?

Sun and colleagues published in Records of Natural Products in 2025. The question was narrow. Does pearl powder do anything measurable to mood-related behavior in a stressed animal, and if so, through what.

How the study was built

The design is worth reading closely, because the details are where the honest limits live.

  • Male Sprague-Dawley rats, four to six weeks old, five per group for the behavior tests
  • A chronic stress protocol run for 28 days using crowding, heat, humidity, flashing light, and noise
  • Treatment only in the final week, once daily, given by gavage
  • Three doses, 16.7, 83.3, and 166.7 milligrams per kilogram

The material given was not raw pearl powder. The researchers dissolved freshwater pearl powder in hydrochloric acid to simulate what stomach acid does to it, then used the protein fraction that came out. Fourteen amino acids were identified in it, and five of them accounted for more than 80 percent of the total, led by glycine at 43.8 percent.

What changed in the behavior

Stressed rats stop caring about sugar water. That loss of interest in a reward is the standard rodent read on anhedonia, and it moved.

  • Sucrose preference was restored by 17.89 percent, with the high dose reaching statistical significance
  • Forced swim immobility time dropped by 12.34 percent
  • Tail suspension immobility time dropped by 12.03 percent
  • The authors describe the effect as dose-dependent rather than a one-dose result

What moved inside the brain tissue

The researchers then looked at hippocampal tissue, and this is where the finding gets specific rather than merely behavioral. Chronic stress had pushed four proteins tied to synaptic function out of balance, and the middle dose pulled them back.

GluN2A rose 22.55 percent. GluN2B, which the authors describe as the damaging side of that pair when it runs high, fell 19.53 percent. PSD-95 came back up, and BDNF, the growth factor most closely associated with synaptic repair, was partially restored at the highest dose.

A behavior result on its own is easy to wave away. A behavior result with a matching protein change underneath it is harder to dismiss, and harder to overstate.

Where does shilajit come into a pearl powder story?

Where does shilajit come into a pearl powder story?

Two reasons. One is formulation. The other is that shilajit has its own rat literature on exactly this axis, published thirteen years earlier.

The stress axis finding

Surapaneni and colleagues (2012), publishing in the Journal of Ethnopharmacology, ran rats through a chronic fatigue model built on forced swimming for 21 consecutive days. The shilajit they used was standardized, with fulvic acids at 56.75 percent and dibenzo-alpha-pyrones at 0.43 percent.

Shilajit reversed the stress-driven rise in immobility, restored climbing behavior, and attenuated anxiety-type behavior in the elevated plus maze, which is the standard rodent anxiety instrument. It also reversed the drop in plasma corticosterone and the loss of adrenal gland weight. The authors read those two together as modulation of the hypothalamic pituitary adrenal axis.

Corticosterone is the rat stress hormone. It is not human cortisol. That distinction holds every time this paper comes up.

The same swim test, read twice

Notice what the two papers share. Both used forced swim immobility as their behavioral readout in a stressed rodent, and both saw it fall. One then looked down at the hormone axis. The other looked up at synaptic proteins in the hippocampus.

That is a coherent picture rather than a coincidence, and it is still a picture drawn entirely in rats.

Worth stating plainly on the hormone question, because it comes up constantly. Shilajit is not a hormone. Fulvic acid supports the body's own estrogen signaling rather than adding hormone to the body. Neither study here measured a sex hormone at all.

How do the two studies compare side by side?

Setting the two rat studies against each other makes both the overlap and the gap obvious.

Sun and colleagues (2025), pearl powder Surapaneni and colleagues (2012), shilajit
Species Male Sprague-Dawley rats, 4 to 6 weeks old Rats
Stress model Chronic mild stress, 28 days Forced swim 15 minutes daily, 21 days
Dose range 16.7 to 166.7 mg/kg, final 7 days 25 to 100 mg/kg, 21 days
Behavior measured Sucrose preference, forced swim, tail suspension Forced swim immobility and climbing, elevated plus maze
Behavior result Sucrose preference restored 17.89%, immobility down about 12% on both tests Immobility reversed, climbing restored, anxiety behavior reduced
Biology measured Hippocampal GluN2A, GluN2B, PSD-95, BDNF Plasma corticosterone, adrenal weight, mitochondrial enzymes
Biology result GluN2A up 22.55%, GluN2B down 19.53%, PSD-95 and BDNF restored Corticosterone and adrenal weight loss reversed
Human relevance None measured, no human trial exists None measured, no human mood trial exists

What does this research honestly not show?

What does this research honestly not show?

The limits go first and they go in full, because on a topic like this an oversold claim is worse than no claim.

  • No human has been tested. Both studies are animal work, and the pearl powder authors list clinical validation as future work they have not done
  • The rats were male. A study in male rodents says nothing direct about a postmenopausal woman's biology, and the entire hormonal premise of this article is absent from the animal model
  • No mood condition was studied, because a rat cannot have one. The forced swim and tail suspension tests are named after the drug class they were built to screen, not after a diagnosis in a person
  • The treatment window was one week, at fixed doses, in a single stress model, on the hippocampus alone. The authors say all of this themselves in their limitations section
  • The pearl powder came from a company that part-funded the work. The authors declared no conflict of interest, and we are noting the funding source anyway because you should be able to see it
  • There is no human shilajit and mood trial either. The stress axis evidence is rat evidence too, and calling it anything else would be dishonest

Here is what it does support, at the level the data earns. Two ingredients in the same box have separate animal evidence on the stress response, from two different directions. That is a reason to find the combination interesting. It is not a reason to expect it to fix how you feel, and we are not going to tell you it will.

On safety, one claim does hold at human level. Across every human study run on shilajit, zero serious adverse events have been reported. That record belongs to shilajit specifically, not to the pearl powder animal data above.

Common questions about pearl powder and mood after menopause

Is there a human study on pearl powder and mood?

No. The 2025 study by Sun and colleagues was run entirely in rats, and the authors themselves list clinical validation as a future step rather than something already done. Nothing in this article describes a result measured in a person.

Does this mean pearl powder treats depression or anxiety?

No, and it should not be read that way. The tests used are named after the drug class they were built to screen in rodents, not after a diagnosis in a person. This research speaks to ordinary emotional ups and downs at the level of animal biology, and it does not support any claim about a diagnosable mood condition.

What did the rats actually receive?

Not raw pearl powder. The researchers dissolved freshwater pearl powder in hydrochloric acid to mimic what stomach acid does to it, then gave the resulting protein fraction by gavage at 16.7, 83.3, or 166.7 milligrams per kilogram once daily for one week.

Why is shilajit in this article at all?

Because pearl powder never ships on its own at Optimum, and because shilajit has its own rat research on the stress response axis. Surapaneni and colleagues found shilajit reversed stress-driven behavior changes and modulated the hypothalamic pituitary adrenal axis in rats, which is the same literature tradition and the same honest ceiling.

Does any of this add estrogen to your body?

No. Shilajit is not a hormone. Fulvic acid, the compound that carries its trace minerals, supports the body's own estrogen signaling, which is a different thing from adding hormone to the body. The pearl powder research described here measured brain proteins and behavior in rats, not hormones at all.

Optimum Shilajit box

Bone Restore Trifecta

Shilajit from the Altai mountains, pearl powder, and bamboo silica in one daily tablet. Third-party lab tested for heavy metals and mycotoxins on every batch, from a small family owned company out of Florida. If the research above is the kind of thing you want behind what you take, here is .

See Optimum Bone Restore Trifecta

Sources

  1. Sun H, Zheng H, Zhang Y, Liu H, Gao F. Pearl Powder Exerts Antidepressant Effects by Modulating the GluN2A/BDNF/PSD-95 Signaling Axis. Records of Natural Products. 2025;19(6):702-716. https://doi.org/10.25135/rnp.551.2506.3569
  2. Surapaneni DK, Adapa SR, Preeti K, Teja GR, Veeraragavan M, Krishnamurthy S. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. Journal of Ethnopharmacology. 2012;143(1):91-99. https://pubmed.ncbi.nlm.nih.gov/22771318/
  3. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry. 2006;63(4):375-382. https://pubmed.ncbi.nlm.nih.gov/16585466/
  4. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of General Psychiatry. 2006;63(4):385-390. https://pubmed.ncbi.nlm.nih.gov/16585467/
  5. Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research. 2014;28(4):475-479. https://pubmed.ncbi.nlm.nih.gov/23733436/